Latest News in the pharma Industry

Research & Development

Eli Lilly expands New York City R&D site

Eli Lilly expands New York City R&D site

9 Oct 2015

Expansion will power immuno-oncology discovery and research collaborations.

Read more 
Boehringer's investigational biologic cleared skin better, faster and for longer than ustekinumab in Phase II psoriasis study

Boehringer's investigational biologic cleared skin better, faster and for longer than ustekinumab in Phase II psoriasis study

9 Oct 2015

Nearly triple the percentage of patients maintained completely clear skin on BI 655066 after nine months, compared to ustekinumab.

Read more 
Concert Pharmaceuticals announces $8 million milestone from Celgene

Concert Pharmaceuticals announces $8 million milestone from Celgene

9 Oct 2015

Phase I clinical evaluation of CTP-730 completed.

Read more 
Horizon Discovery Group in-licenses oncology programme from Servier and enters option agreement

Horizon Discovery Group in-licenses oncology programme from Servier and enters option agreement

7 Oct 2015

Horizon will exploit its translational genomics and combination sciences platform to define optimum approaches to treatment and identify cancer patient populations most likely to respond.

Read more 
Bi-bi breast cancer — new in vitro treatment study begins in oxford

Bi-bi breast cancer — new in vitro treatment study begins in oxford

7 Oct 2015

Redesigned bi-specific antibodies may offer new hope against secondary breast cancer.

Read more 
Flex Pharma demonstrates efficacy of synthesized single and combination agents in reducing human muscle cramps

Flex Pharma demonstrates efficacy of synthesized single and combination agents in reducing human muscle cramps

7 Oct 2015

Presentation at the European Committee for Treatment and Research of Multiple Sclerosis

Read more 
NIH grantees win 2015 Nobel Prize in chemistry

NIH grantees win 2015 Nobel Prize in chemistry

7 Oct 2015

Prize awarded for mapping, at a molecular level, how cells repair damaged DNA and safeguard the genetic information.

Read more 
FDA grants Priority Review for Daklinza (daclatasvir) sNDAs

FDA grants Priority Review for Daklinza (daclatasvir) sNDAs

6 Oct 2015

Three applications are under review for Daklinza in combination with sofosbuvir with or without ribavirin to treat chronic hepatitis C patients with decompensated cirrhosis, post-liver transplant recurrence of HCV, and coinfection with HIV-1.

Read more 
FDA accepts Sandoz regulatory submission for a proposed biosimilar etanercept

FDA accepts Sandoz regulatory submission for a proposed biosimilar etanercept

2 Oct 2015

Sandoz is seeking approval for all indications included in the reference product's label.

Read more 
Regeneron announces collaboration with Mitsubishi Tanabe Pharma for investigational pain therapy fasinumab in Asia

Regeneron announces collaboration with Mitsubishi Tanabe Pharma for investigational pain therapy fasinumab in Asia

2 Oct 2015

NGF antibody fasinumab currently in Phase II/III osteoarthritis trial.

Read more 
Sanofi NDA for lixisenatide accepted for review by FDA

Sanofi NDA for lixisenatide accepted for review by FDA

30 Sep 2015

First New Drug Application for a GLP-1 receptor agonist to include CV outcomes data.

Read more 
New research to deliver cancer-killing viruses to tumour cells

New research to deliver cancer-killing viruses to tumour cells

30 Sep 2015

Oxford scientists announce laboratory success using a new linker technique to bond cell-killing agents to cancer-targeting antibodies

Read more